United States News All stories

MIRA Pharmaceuticals (NASDAQ:MIRA) submitted a Phase 2a clinical trial protocol for Ketamir-2 in chemotherapy-induced peripheral neuropathy (CIPN) following review and feedback from the U.S. Food and Drug Administration.

Applied Materials (NASDAQ:AMAT) announced plans to invest $5 billion in India over the next decade as the semiconductor equipment maker expands its presence in the country.

Atlanticus Holdings (NASDAQ:ATLC) completed the sale of its CAR Auto Finance operations for approximately $71.2 million, ending the company’s Auto Finance segment.

AtlasClear Holdings (NYSE:ATCH) expects preliminary fiscal 2026 revenue of approximately $20.1 million, up about 85% from $10.9 million in fiscal 2025, according to an update from the company.

Clearmind Medicine (NASDAQ:CMND) reported that its Chief of Global Impact Mary-Elizabeth Gifford participated in a U.S. Food and Drug Administration panel focused on potential future therapeutic use of psychedelic drugs.

S&P Global (NYSE:SPGI) agreed to acquire OpenZeppelin, a provider of onchain security standards and smart contract technology, in a transaction announced September 17, 2026.

Almonty Industries (NASDAQ:ALM) entered into a long-term tungsten concentrate supply agreement with Wolfram Bergbau und Hütten AG (WBH), a subsidiary of the Sandvik Group, covering tungsten recovery from existing tailings at the Los Santos Mine in western Spain.

Bank7 Corp. (NASDAQ:BSVN) agreed to acquire 100% of Century Financial Services Corporation, the parent company of Century Bank, under a definitive merger agreement announced September 17, 2026.

Nuvation Bio (NASDAQ:NUVB) received U.S. Food and Drug Administration approval for a supplemental New Drug Application updating efficacy information for IBTROZI (taletrectinib) in TKI-naïve adults with advanced ROS1-positive non-small cell lung cancer.

Bristol Myers Squibb (NYSE:BMY) reported positive two-year results from the Phase 3 POETYK PsA-2 study and its open-label extension, showing continued efficacy and a consistent safety profile for Sotyktu (deucravacitinib) in adults with active psoriatic arthritis.

AECOM (NYSE:ACM) announced that its Board of Directors declared a quarterly cash dividend of $0.31 per share as part of its ongoing dividend program.

Indivior Pharmaceuticals (NASDAQ:INDV) declared a contingent special cash dividend of $8.13 per share, with payment dependent on the completion of its pending merger with Supernus Pharmaceuticals.

Centrus Energy (NYSE:LEU) signed a definitive multi-year contract to supply High-Assay Low-Enriched Uranium (HALEU) to Antares Nuclear, with deliveries scheduled to begin before the end of the decade.

Aquestive Therapeutics (NASDAQ:AQST) resubmitted its New Drug Application (NDA) to the U.S. Food and Drug Administration for Anaphylm (dibutepinephrine) sublingual film, a treatment candidate for Type I allergic reactions including anaphylaxis.

NGL Energy Partners (NYSE:NGL) announced that its Board of Directors declared quarterly distributions for its Class B, Class C and Class D preferred units for the quarter ending September 30, 2026.

Surf Air Mobility (NYSE:SRFM) announced a definitive agreement with Sprintbach Aviation for OperatorOS, its SurfOS flight operations software platform for Part 135 operators powered by Palantir Technologies (NASDAQ:PLTR).

Aethlon Medical (NASDAQ:AEMD) and North Immunology entered a definitive all-stock merger agreement that will combine the companies around NOR-101, a half-life extended IL-13 x IL-18 bispecific antibody being developed for atopic dermatitis and other immune-mediated diseases.

Sanofi (NASDAQ:SNY) and Cheplapharm announced plans to create a strategic partnership under which Cheplapharm would acquire a portfolio of 20 mature medicines and three manufacturing sites from Sanofi, with Sanofi receiving a 26.4% equity stake in Cheplapharm.

Global Net Lease (NYSE:GNL) declared quarterly cash dividends on all outstanding preferred stock series, with payments scheduled for October 15, 2026.

Tower Semiconductor (NASDAQ:TSEM) and NewPhotonics announced the start of high-volume shipments of laser-integrated, serviceable optical engine photonic integrated circuits (PICs) designed for AI data-center interconnects.

111 (NASDAQ:YI) received an unsolicited, preliminary and non-binding proposal from a buyer group to acquire all outstanding Class A ordinary shares not already owned by the group and take the company private.

Brent crude futures declined 1.8% to $103.95 a barrel and U.S. West Texas Intermediate (WTI) futures fell 1.7% to $100.66 a barrel after reports that Saudi Arabia was offering additional crude cargoes through Oman, easing some supply concerns.

Innate Pharma (NASDAQ:IPHA) reported revenue and other income of €5.7 million for the first half of 2026, while posting a net loss of €19.6 million as the biotechnology company adjusted its research and development activities.

Apollo Global Management (NYSE:APO) agreed that Apollo-managed funds will sell an approximately 30% minority stake in UK housebuilder Miller Homes to Daiwa House, while continuing as the company’s controlling shareholder.